Literature DB >> 1109550

The development of cardiac myxomas and papillary endocardial lesions from mural thrombus.

W R Salyer, D L Page, G M Hutchins.   

Abstract

A morphologic study of 466 cardiac mural thrombi, 66 examples of nonbacterial thrombotic endocarditis, 25 myxomas, and 12 papillary endocardial lesions was performed. It appeared that three different sequences of organization of endocardial thrombi are possible. (1) Ordinary mural thrombi are converted into a flat, fibrous scar by fibroblast proliferation and collagen and elastic fiber deposition. (2) Papillary endocardial lesions develop from non bacterial thrombotic endocarditis as additional thrombus material is acquired in some foci and lost in others. No ingrowth of granulation tissue occurs at the base of these lesions. The thrombus material of the papillae is gradually replaced by fibrous tissue, and the lesion eventually is identical to a large Lambl's excrescence. (3) Myxomas enlarge in part as do the papillary endocardial lesions. In addition, their size increases as a result of influx into the myxoma of fluid from the basal granulation tissue. Although myxomas cannot be differentiated from ordinary mural thrombi on the basis of the cellular and ground substance components, their mode of development results in a distinctive appearance. The mature lesion is composed of three zones: a basal layer of small vascular channels, undifferentiated mesenchymal cells, and ground substance; a middle, acellular zone of ground substance; and a cortical layer of mesenchymal cells. The peculiar arrangement of endothelial cells and undifferentiated mesenchymal cells, the examples of apparent atrial wall invasion, and the cases of embolic "metastases" provide no conclusive evidence of neoplasia, since these features may also be seen with ordinary mural thrombi.

Entities:  

Mesh:

Year:  1975        PMID: 1109550     DOI: 10.1016/0002-8703(75)90003-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  19 in total

1.  Surgical experience with cardiac papillary fibroelastoma over a 15-year period.

Authors:  Melissa M Anastacio; Marc R Moon; Ralph J Damiano; Michael K Pasque; Hersh S Maniar; Jennifer S Lawton
Journal:  Ann Thorac Surg       Date:  2012-05-23       Impact factor: 4.330

2.  Mesenteric arteriovenous shunt associated with thrombosis of the portal venous system: case report.

Authors:  N Matsunaga; K Hayashi; H Mori; F Iwano; T Taniguchi; S Nakao
Journal:  Cardiovasc Intervent Radiol       Date:  1988-10       Impact factor: 2.740

3.  Cardiac myxomas: a clinicopathologic profile.

Authors:  L E Wold; J T Lie
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

4.  Central intravascular papillary endothelial hyperplasia of the mandible.

Authors:  A Komori; M Koike; T Kinjo; T Azuma; M Yoshinari; H Inaba; K Hizawa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

5.  A complicated case of mitral valve disease.

Authors:  S E James; R McKay; D N Ross
Journal:  Br Heart J       Date:  1985-03

6.  Case report 689. Metastatic atrial myxoma to the pubis.

Authors:  C Moran; E M Braunstein; T Ulbright; R A Colyer
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

7.  Atrial myxoma: tumour or trauma?

Authors:  J Nolan; P J Carder; P Bloomfield
Journal:  Br Heart J       Date:  1992-05

8.  Cardiac myxoma. Clinical and pathologic features in 15 cases.

Authors:  C Schmid; S Paterakis; J A Likungu; P G Kirchhoff
Journal:  Klin Wochenschr       Date:  1988-08-15

9.  Cardiac Papillary Fibroelastoma: Single-Institution Experience with 14 Surgical Patients.

Authors:  Walid K Abu Saleh; Odeaa Al Jabbari; Basel Ramlawi; Michael J Reardon
Journal:  Tex Heart Inst J       Date:  2016-04-01

10.  Herpes simplex virus type 1 infection associated with atrial myxoma.

Authors:  Yanwen Li; Zhigang Pan; Yuan Ji; Mary Sheppard; Donald J Jeffries; Leonard C Archard; Hongyi Zhang
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.